Does TOLVAPTAN Cause Deep vein thrombosis? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Deep vein thrombosis have been filed in association with TOLVAPTAN (Jynarque). This represents 0.2% of all adverse event reports for TOLVAPTAN.
21
Reports of Deep vein thrombosis with TOLVAPTAN
0.2%
of all TOLVAPTAN reports
1
Deaths
11
Hospitalizations
How Dangerous Is Deep vein thrombosis From TOLVAPTAN?
Of the 21 reports, 1 (4.8%) resulted in death, 11 (52.4%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
Yes, Deep vein thrombosis is listed as a known adverse reaction in the official FDA drug label for TOLVAPTAN.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Off label use (560)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Product dose omission issue (379)
Inappropriate schedule of product administration (376)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which TOLVAPTAN Alternatives Have Lower Deep vein thrombosis Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL